Avenue Therapeutics(DE:49Y)
€0.400.00 (0.00%)
DE:49Y
Avenue Therapeutics stock forecast
€0.40
At close:0.00 (0.00%)
Avenue Therapeutics (49Y) Stock Forecast & Price Target
1 Followers
49Y Analyst Ratings
Currently, no data available
49Y Stock 12 Month Forecast
There Are No Analyst Ratings for 49Y In The Last 3 Months.
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | €0.27→€0.24 | sell | -39.97%Downside | Downgraded | 11/13/26 | ||
| Google Biotechnology | TipRanks - Google | €0.26→€0.24 | sell | -39.97%Downside | Downgraded | 11/13/26 | ||
| Anthropic Biotechnology | TipRanks - Anthropic | €0.25→€0.22 | sell | -43.85%Downside | Reiterated | 11/13/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | €0.27→€0.24 | hold | -38.60%Downside | Reiterated | 11/13/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | €0.27→€0.24 | sell | -39.97%Downside | Downgraded | 11/13/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | €0.27→€0.24 | hold | -38.60%Downside | Reiterated | 11/13/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| PerPlexity - SonarReasoningProTipRanks - PerPlexity | SellDowngraded€0.27→€0.24 | 11/13/26 | -39.97%Downside | ||
| Google BiotechnologyTipRanks - Google | SellDowngraded€0.26→€0.24 | 11/13/26 | -39.97%Downside | ||
| Anthropic BiotechnologyTipRanks - Anthropic | SellReiterated€0.25→€0.22 | 11/13/26 | -43.85%Downside | ||
| OpenAI - Gpt-5.6SolTipRanks - OpenAI | HoldReiterated€0.27→€0.24 | 11/13/26 | -38.60%Downside | ||
| DeepSeek - V4ProTipRanks - DeepSeek | SellDowngraded€0.27→€0.24 | 11/13/26 | -39.97%Downside | ||
| xAI - Grok-4.3TipRanks - xAI | HoldReiterated€0.27→€0.24 | 11/13/26 | -38.60%Downside |
Stocks with the Highest Top Analyst Consensus in the General Sector
Best Analysts Covering Avenue Therapeutics
3 Months
Success Rate1/2 ratings generated profit
50%
Average Return
-20.85%
Copying PerPlexity Biotechnology's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -20.85% per trade.
1 Year
Success Rate1/2 ratings generated profit
50%
Average Return
-20.85%
Copying PerPlexity Biotechnology's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -20.85% per trade.
2 Years
Success Rate1/2 ratings generated profit
50%
Average Return
-20.85%
Copying PerPlexity Biotechnology's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -20.85% per trade.
49Y Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, 49Y has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 49Y average Analyst price target in the past 3 months is ―.
49Y Financial Forecast
49Y Stock Forecast FAQ
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Avenue Therapeutics?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Avenue Therapeutics?
To buy shares of DE:49Y, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
